Decreased Plasma Tissue Factor Pathway Inhibitor Activity in Ischemic Stroke PatientsTakeo Abumiya, Hisao Kato, Takenori Yamaguchi et al.|Thrombosis and Haemostasis|1995Cited by 47
Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation ― SAMURAI-NVAF Study ―Sohei Yoshimura, Shunya Takizawa, Yasuhiro Hasegawa et al.|Circulation Journal|2018Cited by 44
Prior Anticoagulation and Short‐ or Long‐Term Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients With Nonvalvular Atrial FibrillationKeisuke Tokunaga, Masato Osaki, Masatoshi Koga et al.|Journal of the American Heart Association|2019Cited by 17
Cerebral Small Vessel Disease Burden for Bleeding Risk during Antithrombotic Therapy: Bleeding with Antithrombotic Therapy 2 StudyKanta Tanaka, Kaori Miwa, Masatoshi Koga et al.|Annals of Neurology|2023Cited by 8
Abstract WP398: Timing of Starting Doacs and Short- and Long-Term Clinical Outcomes for Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation: The Samurai-nvaf StudyTadataka Mizoguchi, Ḱazunori Toyoda, Masahito Takagi et al.|Stroke|2018Cited by 0